Skip to content

Clinical trials

Lupus Erythematosus, Systemic trials in Serbia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Systemic Country / region: Serbia Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20081
20112
20122
20152
20161
20171
20182
20192
20201
20213
20225
20232
20242
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Active, not recruiting5
Terminated5
Recruiting4
Enrolling by invitation3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biogen4
Eli Lilly and Company3
UCB Biopharma SRL3
Amgen2
Janssen Research & Development, LLC2
Viatris Innovation GmbH2
AbbVie1
Ablynx, a Sanofi company1
AstraZeneca1
Biotest1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic30
Autoimmune Diseases5
Connective Tissue Diseases4
Immune System Diseases4
Lupus Erythematosus, Cutaneous4
Lupus Erythematosus, Discoid3
Inflammation1
Lupus Nephritis1
Mycobacterium Infections, Nontuberculous1
Nephritis1

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.